Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine and Melphalan Conditioning Prior to Allogeneic Stem Cell Transplant for Myelodysplasia or Acute Leukemia
NCT01885689Phase 2Active, not recruiting
- Sponsor
- City of Hope
- Start
- Feb 2014
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine, melphalan in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), sponsored by City of Hope. Started Feb 2014; status: active, not recruiting.
02
Drugs
clofarabinemelphalan
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on NCT01885689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01885689.